We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SEC

News List

Walgreens Boots Alliance Announces Agreement with SEC americanpharmaceuticalreview
September 29, 2018
Walgreens Boots Alliance announced the company has reached an agreement with the Securities and Exchange Commission (SEC) to fully resolve an investigation into forward-looking financial goals and related disclosures by Walgreen Co. (Walgreens).
SEC hands Clovis $20M penalty for allegedly misleading investors fiercepharma.com
September 20, 2018
Clovis Oncology may have ditched development of cancer treatment rociletinib years ago, but the drug is going to cost the company, its CEO and its former CFO more than $20 million.
SEC charges ex-Sangamo exec with insider trading fiercebiotech
August 27, 2018
The SEC has charged former Sangamo BioSciences executive Winson Tang with insider trading. Tang is accused of telling a friend about a 2014 agreement between Sangamo and Biogen before the news became public.

Previous page 1 2 3 4 5 Next page